Moderna (MRNA) Preferred Shares Issued (2018)

Moderna (MRNA) has disclosed Preferred Shares Issued for 1 consecutive years, with $111.6 million as the latest value for Q2 2018.

On a quarterly basis, Preferred Shares Issued changed N/A to $111.6 million in Q2 2018 year-over-year; TTM through Mar 2019 was $111.6 million, a N/A change, with the full-year FY2018 number at $661.1 million, changed N/A from a year prior.
Preferred Shares Issued was $111.6 million for Q2 2018 at Moderna, down from $549.5 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $549.5 million in Q1 2018 to a low of $111.6 million in Q2 2018.

Peer Comparison